GeneDiscovery Co., Ltd.: Q1 2026 EPS -0.76 NTD
GeneDiscovery Co., Ltd. announced its Q1 2026 financial results, reporting an EPS of -0.76 NTD, revenue of 124 million NTD, and net profit after tax of -48 million NTD. This indicates a financial loss for the company in the biotech and medical industry.
📋 Article Processing Timeline
- 📰 Published: March 1, 2026 at 09:00
- 🔍 Collected: May 9, 2026 at 08:00 (1655h 0m after Published)
- 🤖 AI Analyzed: May 9, 2026 at 08:21 (20 min after Collected)
Company Code: 6645
Company Name: GeneDiscovery Co., Ltd.
Industry: Biotech and Medical Industry
Year/Quarter: Q1 2026
Basic Earnings Per Share: -0.76 NTD
Operating Revenue: 124 million NTD
Net Profit After Tax: -48 million NTD
Company Name: GeneDiscovery Co., Ltd.
Industry: Biotech and Medical Industry
Year/Quarter: Q1 2026
Basic Earnings Per Share: -0.76 NTD
Operating Revenue: 124 million NTD
Net Profit After Tax: -48 million NTD